Harvard Business Review has published an analysis titled "How Gen AI is Disrupting B2B Buying Decisions," placing the technology's influence on the buyer's side of the table under the microscope.

The headline alone signals a shift in how the sales conversation is being framed. For the past two years, most vendor commentary and sales-enablement coverage has concentrated on generative AI as a seller-side tool: drafting emails, summarizing calls, populating CRM fields. HBR's framing puts the counterparty — the buying committee — at the center of the disruption instead.

That distinction matters for revenue teams. If generative AI changes how procurement teams, end users, and economic buyers research vendors, evaluate shortlists, and justify purchase decisions internally, then the workflow changes sellers experience will not come primarily from their own tech stack. They will come from the questions buyers arrive with, the comparison materials buyers generate themselves, and the point in the cycle at which a human seller first adds marginal value.

The publication itself carries weight here. Harvard Business Review is a peer-reviewed-adjacent management outlet with a readership heavy in decision-makers — precisely the buying-committee roles the piece addresses. When the audience being analyzed is also the audience reading the analysis, adoption of the described behaviors tends to follow quickly rather than gradually.

For sales leadership, the practical questions the HBR piece raises are straightforward to state even before parsing its full argument. At which deal stages does an AI-informed buyer behave differently from a traditionally researched one? Which parts of the seller's value proposition — product information, pricing context, implementation guidance — can buyers now source autonomously? And where does that leave the discovery call, the demo, and the business case?

The article's title asserts disruption; the body of evidence behind that claim is what sellers will need to evaluate against their own pipeline data. Vendor-side claims about AI-transformed selling are abundant and rarely methodologically grounded. An HBR treatment offers a rarer commodity: an examination of the buy side, where measurement is harder and where the consequences for win rates and cycle times land first.

Quota Brief will track follow-on research and practitioner responses to the piece, particularly any quantified data on how AI-assisted buying behavior correlates with deal outcomes across different team sizes and sales motions.